AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02265029 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Immediate spa treatment
Description: spa treatment in rheumatology with sedative and antalgique techniques and mobilizing techniques (rehabilitation in pool)
Study NCT04490941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ophthalmologist-delivered health education
Description: The educational intervention will be conducted on-site by a qualified, experienced ophthalmologist at an ophthalmic center with goals of building awareness on diabetes symptoms, particularly on diabetic retinopathy, and its risk factors with appropriate management.
Study NCT02265029 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Late spa treatment
Description: spa treatment in rheumatology with sedative and antalgique techniques and mobilizing techniques (rehabilitation in pool)
Study NCT02226172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glasdegib (PF-04449913)
Description: Oral daily dose of glasdegib (PF-04449913) 100 mg tablet in a continuous regimen of 28-day cycles.
Study NCT02226172 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral daily dose of placebo 100 mg tablet in a continuous regimen of 28-day cycles.
Study NCT03760822 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ramucirumab
Description: IV ramucirumab at 8 mg/kg on D1 and D15
Study NCT03760822 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ramucirumab
Description: IV ramucirumab at 8 mg/kg on D1 and D15
Study NCT03760822 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: IV paclitaxel at 80 mg/m² on D1, D8 and D15
Study NCT04490941 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual care
Description: Usual care follows standard procedure on diabetes management similar to the routine service provision.
Study NCT01900691 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Evolution® Esophageal Stent - Fully Covered
Description: Placement of the Evolution® Esophageal Stent for benign or malignant strictures, fistulas, perforations or leaks with the intention of removal
Study NCT01026363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ergocalciferol
Description: Ergocalciferol 50,000 IU capsule, one dose every other day x 5 doses
Study NCT01026363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol
Description: 0.25 mcg tablet once daily for 14 days
Study NCT03827291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exparel
Description: Bilateral administration on each side of 30 ml aliquot containing 10 ml of liposomal bupivacaine (133 mg) and 20 ml of 0.25% bupivacaine (50 mg) in the fascial plane between the QL and psoas major muscles.
Study NCT03827291 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Thoracic epidural analgesia
Description: Historical cohort that received thoracic epidural analgesia
Study NCT04658745 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation
Description: iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients, by using a butterfly shape coil.
Study NCT04658745 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Intermittent theta burst stimulation
Description: iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients, by using a butterfly shape coil.
Study NCT04658745 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Mirror Therapy
Description: Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.
Study NCT01466764 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anakinra
Description: An injection of 100 mg Anakinra was administered 1 hour prior to surgery and again 24 hours following surgery.
Study NCT01466764 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: An injection of normal saline was administered 1 hour prior to surgery and again 24 hours following surgery.
Study NCT04879498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monolithic zirconia
Description: To assess the clinical performance and survival of posterior monolithic zirconia fixed partial dentures
Study NCT04879498 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Veneered zirconia
Description: To assess the clinical performance and survival of posterior veneered zirconia fixed partial dentures
Study NCT04879498 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Metal-ceramic
Description: To assess the clinical performance and survival of posterior metal-ceramic fixed partial dentures
Study NCT04658745 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mirror Therapy
Description: Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.
Study NCT04658745 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham intermittent theta burst stimulation
Description: iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. However, a sham coil will be used, which is not associated with any stimulation effect on the brain.
Study NCT04065282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: 3 cycles before radical surgery
Study NCT04065282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 85mg/m2 Q3W, 3 cycles perioperation
Study NCT04065282 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000mg/m2 bid po D1\~14 Q3W, 3 cycles perioperation
Study NCT04136535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Pemetrexed，500mg/m²，ivgtt ，d1，q3w
Study NCT04136535 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed，500mg/m²，ivgtt ，d1，q3w
Study NCT04136535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin，AUC 5.0，ivgtt，d1，q3w，
Study NCT04136535 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin，AUC 5.0，ivgtt，d1，q3w，
Study NCT04136535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib
Description: Anlotinib ，12 mg，po，qd，d1-14，q3w；
Study NCT01713790 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stochastic resonance whole-body vibration
Description: Stochastic resonance whole-body vibration training program over 10 weeks, three times a week with 3 to 6 Hz, Noise 4.
Study NCT01713790 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exergame
Description: training program over 10 weeks, three times a week.
Study NCT01713790 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Leg press
Description: training program over 10 weeks, three times a week.
Study NCT02869269 — intervention group
Intervention type: DEVICE
Intervention: Early stage
Description: patients who classed as clinical stage 1 and 2
Study NCT02869269 — intervention group
Intervention type: DEVICE
Intervention: Late stage
Description: patients who classed as clinical stage 3 and 4
Study NCT02676986 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enzalutamide
Description: Anti-androgen
Study NCT02676986 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exemestane
Description: Hormonal therapy (Licenced)
Study NCT03000673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: Specified dose of Enoxaparin on specified days
Study NCT04658745 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham mirror Therapy
Description: In sham mirror therapy, the mirror will be covered. Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to move the non-affected hand. The participants cannot receive mirror visual feedback of the paretic upper extremity movement during the therapy. Same as mirror therapy, the movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: White rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: White rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Brown rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Brown rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study NCT03000673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin (UFH)
Description: Specified dose of UFH on specified days
Study NCT03000673 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BMS-986177
Description: Specified dose of BMS-986177 on specified day
Study NCT00267111 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Eucerin plus
Description: 1g, single application
Study NCT00267111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amethocaine gel 4%
Description: 1 g, single application
Study NCT02270073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy of trainee therapists
Description: In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.
Study NCT02270073 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavior therapy of trainee therapists
Description: In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.
Study NCT02270073 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive behavior therapy of trainee therapists
Description: In all three treatment arms, trainee therapists perform a cognitive behavior therapy (CBT) under conditions of the German health care system. This treatment is not a manualized intervention, but rather based on individualized treatment plans that have been developed together with expert supervisors during a five session diagnostic stage. Treatment duration is 25 sessions, while on average every fourth is supervized by an CBT expert therapist.
Study NCT04100200 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Mixed berries
Description: Strawberry and red raspberry
Study NCT04100200 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: FOS
Description: Fructo-oligosaccharide
Study NCT04100200 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Placebo similar in color to mixed berry supplement without any polyphenols
Study NCT04100200 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Combination
Description: Mixed berry composite + FOS
Study NCT05908890 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental Denture Adhesive
Description: Adhesive will be applied to the partial denture(s) by a dental professional separate from the examiner and subject.
Study NCT05908890 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fixodent True Feel Denture Adhesive
Description: Adhesive will be applied to the partial denture(s) by a dental professional separate from the examiner and subject.
Study NCT02368002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral weight loss therapy
Description: All participants start with behavioral weight loss therapy which consists of 20 weekly meetings wtih a weight loss coach. Session components will include weekly weigh-in, discussion of progress and challenges and discussion of scheduled session topic. Dietary goals and physical activity goals are set. After their first session, participants are randomized to have their weight assessed at either their 3rd session or their 7th session. Both the participant and their coach are blinded to the randomization. If the participant has lost the expected amount of weight, they continue with behavioral weight loss therapy for the full 20 session.
Study NCT02368002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portion-controlled meals
Description: Participants continue with behavioral weight loss therapy, but this is augmented with portion-controlled meals (PCM). Adherence to energy intake goals is facilitated by consuming pre-prepared meals specifically designed to meet caloric intake guidelines. PCMs reduce individuals' motivationally- and self-regulatory-dependent planning and decision making around eating. PCMs also serve as a teaching tool regarding the amount and type of food people should eat in order to produce weight loss.
Study NCT02368002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment
Description: Switching the therapeutic approach to an enhanced behavioral weight loss therapy teaching acceptance-based behavioral skills theoretically addresses the root problem of many weight loss challenges and boosts long-term capacity for self-regulation. Acceptance based strategies are designed to help participants identify and internalize values and lasting commitment to behavior consistent with these values. The strategies focus on increasing people's ability to forgo more pleasurable options (e.g., hedonic pleasure of food) in favor of behavior that is distinctly less pleasurable or even aversive (remaining hungry, anxious, bored). The inability to tolerate such distress is directly associated with failure of self-regulation.
Study NCT04957732 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (SoC)
Description: SoC consisted of irrigation with normal saline, using the same proprietary abscess irrigation tip as the Irrisept arm. SoC was used at the initial visit and at each subsequent 48-hour visit interval (up to 96 hours) until abscess healing.
Study NCT02747433 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robot-Assisted Therapy (RT)
Description: Highly repetitive robot-assisted therapy for paretic arm with Armeo (1 hr sessions, 3x week for 3 weeks) followed by robot-assisted therapy for hand motions with Amadeo (3x week for 3 weeks). Robot training to be accompanied with ALPS motor learning program directed toward UE self management and transfer of training to daily activities in home \& community.
Study NCT02747433 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robot & Task-Oriented Training (RT-TOT)
Description: Highly repetitive robot-assisted therapy for paretic arm with Armeo (30 min sessions, 3x week for 3 weeks) followed by robot-assisted therapy for hand motions with Amadeo (3x week for 3 weeks). Task oriented training will be delivered for remaining 30 mins of each treatment session. Robot and task oriented training to be accompanied with ALPS motor learning program directed toward UE self management and transfer of training to daily activities in home \& community.
Study NCT04179409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amondys 45
Description: This drug is used to target skipping of exon 45 of the dystrophin gene.
Study NCT04179409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exondys 51
Description: This drug is used to target skipping of exon 51 of the dystrophin gene.
Study NCT04179409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vyondys 53
Description: This drug is used to target skipping of exon 53 of the dystrophin gene.
Study NCT03416062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remaxol®
Description: Solution for intravenous infusions, containing succinate, methionine, inosine, and nicotinamide in 400 ml glass bottle
Study NCT03416062 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ringer's Solution
Description: Solution for intravenous infusion, 400 or 800 ml
Study NCT03416062 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ringer's Solution
Description: Solution for intravenous infusion, 400 or 800 ml
Study NCT01236547 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT
Study NCT01236547 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT
Study NCT01236547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV
Study NCT01236547 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Given IV
Study NCT01236547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib Hydrochloride
Description: Given PO
Study NCT01236547 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT03466593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Description: Prehabilitation concerning eating, smoking, drinking and physical activity
Study NCT03466593 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine care
Description: Preoperative information
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Black rice diet
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min
Study NCT03466593 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extra early mobilization
Description: Mobilization the day of surgery
Study NCT03466593 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard mobilization
Description: Mobilization the day after surgery
Study NCT01932086 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bread
Description: All test foods contained 50 g available carbohydrate from the test food products. A glass of 250 ml water was served together with the clinical trial food, and the participants were instructed to ingest the breakfast with 15 min